Gayeon Kim

Gayeon Kim

Auto-generated profile, based on publicly available information

Gayeon Kim

Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJi Yeon Lee
Ji Yeon Lee
YKYou-Jin Kim
You-Jin Kim
ECEun Hee Chung
Eun Hee Chung
DCDae Won Cho
Dae Won Cho
IJIna Jeong
Ina Jeong
JJJoon-Sung Joh
Joon-Sung Joh
In 2015, the largest outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection outside the Middle East occurred in South Korea. We summarized the epidemiological, clinical, and laboratory findings of the first Korean case of MERS-CoV and analyzed whole-genome sequences of MERS-CoV derived from the patient. A 68-year-old man developed fever and myalgia 7 days after returning to Korea, following a 10-day trip to the Middle East. Before diagnosis, he visited 4 hospitals, potentially resulting in secondary transmission to 28 patients. On admission to the National Medical Center (day 9, post-onset of clinical illness), he presented with drowsiness, hypoxia, and multiple patchy infiltrations on the chest radiograph. He was intubated (day 12) because of progressive acute respiratory distress syndrome (ARDS) and INF-α2a and ribavirin treatment was commenced. The treatment course was prolonged by superimposed ventilator associated pneumonia. MERS-CoV PCR results converted to negative from day 47 and the patient was discharged (day 137), following rehabilitation therapy. The complete genome sequence obtained from a sputum sample (taken on day 11) showed the highest sequence similarity (99.59%) with the virus from an outbreak in Riyadh, Saudi Arabia, in February 2015. The first case of MERS-CoV infection had high transmissibility and was associated with a severe clinical course. The patient made a successful recovery after early treatment with antiviral agents and adequate supportive care. This first case in South Korea became a super-spreader because of improper infection control measures, rather than variations of the virus.

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
RCRan-Hui Cha
Ran-Hui Cha
JJJoon-Sung Joh
Joon-Sung Joh
IJIna Jeong
Ina Jeong
JLJi Yeon Lee
Ji Yeon Lee
HSHyoung-shik Shin
Hyoung-shik Shin
CCCritical Care Team of National Medical Center
Critical Care Team of National Medical Center
Cha RH, et al. J Korean Med Sci. 2015 Dec;30(12):1807-1814. http://dx.doi.org/10.3346/jkms.2015.30.12.1807

1 January 2011 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
GKGayeon Kim
Gayeon Kim
MCMin-Ho Choi
Min-Ho Choi
JKJae-Hwan Kim
Jae-Hwan Kim
YKYu Min Kang
Yu Min Kang
HJHee Jung Jeon
Hee Jung Jeon
MOMyoung-Don Oh
Myoung-Don Oh
Kim G, et al. J Korean Med Sci. 2011 Dec;26(12):1630-1633. http://dx.doi.org/10.3346/jkms.2011.26.12.1630

7 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ILInhan Lee
Inhan Lee
JKJoohae Kim
Joohae Kim
YYYohwan Yeo
Yohwan Yeo
JLJi Yeon Lee
Ji Yeon Lee
IJIna Jeong
Ina Jeong
JKJunghyun Kim
Junghyun Kim
The frequency and clinical manifestation of lung fibrosis accompanied by coronavirus disease (COVID-19) are not well-established. We aimed to identify the factors attributed to post-COVID-19 fibrosis. This single-center prospective study included patients diagnosed with COVID-19 pneumonia from 12 April to 22 October 2021 in the Republic of Korea. The primary outcome was the presence of pulmonary fibrosis on a CT scan 3 months after discharge; the fibrosis risk was estimated by a multiple logistic regression. The mean patient age was 55.03 ± 12.32 (range 27–85) years; 65 (66.3%) were men and 33 (33.7%) were women. The age, Charlson Comorbidity Index, lactate dehydrogenase level, aspartate aminotransferase level, and Krebs von den Lungen-6 level were significantly higher and the albumin level and the saturation of the peripheral oxygen/fraction of inspired oxygen (SpO2/FiO2) ratio were significantly lower in the fibrosis group than in the non-fibrosis group; the need for initial oxygen support was also greater in the fibrosis group. An older age (adjusted odds ratio (AOR) 1.12; 95% confidence interval (CI) 1.03–1.21) and a lower initial SpO2/FiO2 ratio (AOR 7.17; 95% CI 1.72–29.91) were significant independent risk factors for pulmonary fibrosis after COVID-19 pneumonia. An older age and a low initial SpO2/FiO2 ratio were crucial in predicting pulmonary fibrosis after COVID-19 pneumonia.

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JUJihye Um
Jihye Um
YCYoun Young Choi
Youn Young Choi
GKGayeon Kim
Gayeon Kim
MKMin-Kyung Kim
Min-Kyung Kim
KLKyung-Shin Lee
Kyung-Shin Lee
JJJaehyun Jeon
Jaehyun Jeon
Um J, et al. J Korean Med Sci. 2022 Feb;37(9):e70. https://doi.org/10.3346/jkms.2022.37.e70

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
GKGayeon Kim
Gayeon Kim
HHHyo-Lim Hong
Hyo-Lim Hong
SKSo Yeon Kim
So Yeon Kim
HLHye Ryun Lee
Hye Ryun Lee
DKDong Geun Kim
Dong Geun Kim
YKYeonjae Kim
Yeonjae Kim
Kim G, et al. J Korean Med Sci. 2019 Jan;34(3):e23. https://doi.org/10.3346/jkms.2019.34.e23